In addition, it is quite clear that VDR ligands directly target also Th17 cell subtype, as shown by the reduction of Th17 cytokines, such as IL-17A, IL-17F, and IL-22 by memory T cells in patients with early rheumatoid arthritis (RA) [91]. The gene discussed is IL17F; the disease is rheumatoid arthritis.